Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response

Magnetic Resonance in Medicine

Volumn 70, Issue 1, 2013, Pages 216-224

  Dula, Adrienne N ^a,b   Arlinghaus, Lori R ^a   Dortch, Richard D ^a,b   Dewey, Blake E ^a   Whisenant, Jennifer G ^a,c   Ayers, Gregory D ^b   Yankeelov, Thomas E ^a,b,c,d,e   Smith, Seth A ^a,b,c,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

3 T; breast cancer; chemical exchange saturation transfer; reproducibility

Indexed keywords

AMIDES; CHEMOTHERAPY; CROSSLINKING; DISEASE CONTROL; DISEASES; MAMMALS; PROTEINS; PROTON TRANSFER; TISSUE;

AMIDE PROTON TRANSFERS; BOVINE SERUM ALBUMINS; BREAST CANCER; CHEMICAL EXCHANGE SATURATION TRANSFER; INDIVIDUAL DIFFERENCES; LOCALLY ADVANCED BREAST CANCER; NEOADJUVANT CHEMOTHERAPIES; REPRODUCIBILITIES;

MEDICAL IMAGING;

BOVINE SERUM ALBUMIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT THERAPY; ADULT; AMIDE PROTON TRANSFER IMAGING; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CHEMICAL EXCHANGE SATURATION TRANSFER; CLINICAL ARTICLE; CONTRAST; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PHANTOM; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; TEST RETEST RELIABILITY; TREATMENT RESPONSE;

EID: 84879412534     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24450     Document Type: Article

References (42)

1. Wolff SD, Balaban RS,. NMR imaging of labile proton-exchange. J Magn Reson 1990; 86: 164-169.
2. van Zijl PCM, Zhou J, Mori N, Payen JF, Wilson D, Mori S,. Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med 2003; 49: 440-449.
3. Ward KM, Aletras AH, Balaban RS,. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143: 79-87.
4. Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR,. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics 2009; 29: 759-774.
5. Jones CK, Schlosser MJ, van Zijl PC, Pomper MG, Golay X, Zhou J,. Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med 2006; 56: 585-592.
6. Zhou JY, Payen JF, Wilson DA, Traystman RJ, van Zijl PCM,. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085-1090.
7. Jokivarsi KT, Grohn HI, Grohn OH, Kauppinen RA,. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med 2007; 57: 647-653.
8. Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC,. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 2008; 60: 842-849.
9. Salhotra A, Lal B, Laterra J, Sun PZ, van Zijl PCM, Zhou JY,. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed 2008; 21: 489-497.
10. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC,. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 2003; 50: 1120-1126.
11. van Zijl PC, Yadav NN,. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011; 65: 927-948.
12. Wen ZB, Hu SG, Huang FH, Wang XL, Guo LL, Quan XY, Wang SL, Zhou JY,. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage 2010; 51: 616-622.
13. Filippi M, Rocca MA,. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252 Suppl. 5: v16-v24.
14. Yankeelov TE, Gore JC,. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2009; 3: 91-107.
15. Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, Mahankali S, Gao JH,. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172-178.
16. Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L,. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 2003; 228: 63-69.
17. Hayes C, Padhani AR, Leach MO,. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002; 15: 154-163.
18. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ,. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999; 1: 113-117.
19. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000; 18: 1689-1695.
20. Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J,. Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med 2002; 43: 325-329.
21. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R,. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993; 11: 2101-2111.
22. Rousseau C, Devillers A, Sagan C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006; 24: 5366-5372.
23. Liang AL, Vavasour IM, Madler B, Traboulsee AL, Lang DJ, Li DK, Mackay AL, Laule C,. Short-term stability of T (1) and T(2) relaxation measures in normal appearing white matter. J Neurol 2011; 259: 1151-1158.
24. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S, Stirling JJ, Padhani AR,. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002; 15: 132-142.
25. Bryant RG,. The dynamics of water-protein interactions. Annu Rev Biophys Biomol Struct 1996; 25: 29-53.
26. Fournier LS, Vanel D, Athanasiou A, et al. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels. Eur J Radiol 2009; 69: 43-49.
27. Dortch RD, Li K, Gochberg DF, Welch EB, Dula AN, Tamhane AA, Gore JC, Smith SA,. Quantitative magnetization transfer imaging in human brain at 3 T via selective inversion recovery. Magn Reson Med 2011; 66: 1346-1352.
28. Edden RA, Smith SA, Barker PB,. Longitudinal and multi-echo transverse relaxation times of normal breast tissue at 3 Tesla. J Magn Reson Imaging 2010; 32: 982-987.
29. Miller DH, Thompson AJ, Filippi M,. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003; 250: 1407-1419.
30. Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, Chang A, Ransohoff RM, Fisher E,. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011; 70: 764-773.
31. Schmitt B, Zamecnik P, Zaiß M, Rerich E, Schuster L, Bachert P, Schlemmer H-P,. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results. Fortschr Ron̈tgenstr 2011; 183: 1030-1036.
32. Alonzi R, Padhani AR, Maxwell RJ, Taylor NJ, Stirling JJ, Wilson JI, d'Arcy JA, Collins DJ, Saunders MI, Hoskin PJ,. Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans. Br J Cancer 2009; 100: 644-648.
33. Padhani A,. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization. Radiology 2009; 250: 324-326.
34. Zhu H, Jones CK, van Zijl PCM, Barker PB, Zhou J,. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med 2010; 64: 638-644.
35. Li SP, Makris A, Taylor NJ, Beresford MJ, Ah-See MLW, Stirling JJ, Collins DJ, d'Arcy JA, Leach MO, Padhani AR,. Greater anti-angiogenic effects with docetaxel compared with anthracyclines in the neoadjuvant treatment of breast cancer. Cancer Res 2009; 69: 768S-768S.
36. Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 2009; 19: 2728-2738.
37. Schmid VJ, Whitcher B, Padhani AR, Yang GZ,. Quantitative analysis of dynamic contrast-enhanced MR images based on Bayesian P-splines. IEEE Trans Med Imaging 2009; 28: 789-798.
38. Mulkern RV, Williams ML,. The general-solution to the Bloch equation with constant RF and relaxation terms-application to saturation and slice selection. Med Phys 1993; 20: 5-13.
39. Li S, Makris A, Taylor NJ, Ah-See MW, Wellsted D, Beresford MJ, Stirling JJ, Collins DJ, d'Arcy JA, Padhani AR,. Disease characterisation of triple negative breast carcinomas using functional MRI. EJC Suppl 2009; 7: 171.
40. Sun PZ,. Simultaneous determination of labile proton concentration and exchange rate utilizing optimal RF power: radio frequency power (RFP) dependence of chemical exchange saturation transfer (CEST) MRI. J Magn Reson 2010; 202: 155-161.
41. Jones CK, Polders D, Hua J, Zhu H, Hoogduin HJ, Zhou J, Luijten P, van Zijl PC,. In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med 2012; 67: 1579-1589.
42. Figueiras RG, Goh V, Padhani AR, Naveira AB, Caamaño AG, Martin CV,. The role of functional imaging in colorectal cancer. Am J Roentgenol 2010; 195: 54-66.